{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:10:57Z","timestamp":1759777857695},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/hr.2016.110","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T06:02:52Z","timestamp":1472104972000},"page":"61-66","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke"],"prefix":"10.1038","volume":"40","author":[{"given":"Saya","family":"Ozaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Kumon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirabe","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Ohue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitsuo","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,25]]},"reference":[{"key":"BFhr2016110_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2013.80","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M, Ito S, Itoh H, Iwao H, Kai H, Kario K, Kashihara N, Kawano Y, Kim-Mitsuyama S, Kimura G, Kohara K, Komuro I, Kumagai H, Matsuura H, Miura K, Morishita R, Naruse M, Node K, Ohya Y, Rakugi H, Saito I, Saitoh S, Shimada K, Shimosawa T, Suzuki H, Tamura K, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Umemura S, Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res 2014; 37: 253\u2013390.","journal-title":"Hypertens Res"},{"key":"BFhr2016110_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5853\/jos.2013.15.1.21","volume":"15","author":"K Toyoda","year":"2013","unstructured":"Toyoda K . Epidemiology and registry studies of stroke in Japan. J Stroke 2013; 15: 21\u201326.","journal-title":"J Stroke"},{"key":"BFhr2016110_CR3","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1161\/01.STR.31.11.2616","volume":"31","author":"Y Tanizaki","year":"2000","unstructured":"Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M . Incidence and risk factors for subtypes of cerebral infarction in a general population: The Hisayama Study. Stroke 2000; 31: 2616\u20132622.","journal-title":"Stroke"},{"key":"BFhr2016110_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000078749","volume":"18","author":"K Kimura","year":"2004","unstructured":"Kimura K, Kazui S, Minematsu K, Yamaguchi T, Japan Multicenter StrokeInvestigator\u2019s Collaboration. Analysis of 16922 patients with acute ischemic stroke and transient ischemic attack in japan: a hospital-based prospective registration study. Cerebrovasc Dis 2004; 18: 47\u201356.","journal-title":"Cerebrovasc Dis"},{"key":"BFhr2016110_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/hr.2015.8","volume":"38","author":"N Saji","year":"2015","unstructured":"Saji N, Kimura K, Yagita Y, Kawarai T, Shimizu H, Kita Y . Comparison of arteriosclerotic indicators in patients with ischemic stroke: ankle-brachial index, brachial-ankle pulse wave velocity and cardio-ankle vascular index. Hypertens Res 2015; 38: 323\u2013328.","journal-title":"Hypertens Res"},{"key":"BFhr2016110_CR6","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1161\/01.STR.29.10.2118","volume":"29","author":"JT Moroney","year":"1998","unstructured":"Moroney JT, Bagiella E, Paik MC, Sacco RL, Desmond DW . Risk factors for early recurrence after ischemic stroke: the role of stroke syndrome and subtype. Stroke 1998; 29: 2118\u20132124.","journal-title":"Stroke"},{"key":"BFhr2016110_CR7","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1227\/NEU.0b013e31820f156c","volume":"68","author":"R Gupta","year":"2011","unstructured":"Gupta R, Tayal AH, Levy EI, Cheng-Ching E, Rai A, Liebeskind DS, Yoo AJ, Hsu DP, Rymer MM, Zaidat OO, Lin R, Natarajan SK, Nogueira RG, Nanda A, Tian M, Hao Q, Abou-Chebl A, Kalia JS, Nguyen TN, Chen M, Jovin TG . Intra-arterial thrombolysis or stent placement during endovascular treatment for acute ischemic stroke leads to the highest recanalization rate: results of a multicenter retrospective study. Neurosurgery 2011; 68: 1618\u20131622; discussion 1622\u20131613.","journal-title":"Neurosurgery"},{"key":"BFhr2016110_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/jnis.2009.001081","volume":"2","author":"MS Hussain","year":"2010","unstructured":"Hussain MS, Lin R, Cheng-Ching E, Jovin TG, Moskowitz SI, Bain M, Horowitz M, Gupta R . Endovascular treatment of carotid embolic occlusions has a higher recanalization rate compared with cardioembolic occlusions. J Neurointerv Surg 2010; 2: 71\u201373.","journal-title":"J Neurointerv Surg"},{"key":"BFhr2016110_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/STROKEAHA.108.516377","volume":"40","author":"DT Laskowitz","year":"2009","unstructured":"Laskowitz DT, Kasner SE, Saver J, Remmel KS, Jauch EC, BRAIN Study Group. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke 2009; 40: 77\u201385.","journal-title":"Stroke"},{"key":"BFhr2016110_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/qjmed\/95.1.3","volume":"95","author":"M Mazzali","year":"2002","unstructured":"Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J . Osteopontin: a molecule for all seasons. QJM 2002; 95: 3\u201313.","journal-title":"QJM"},{"key":"BFhr2016110_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1042\/CS20060074","volume":"111","author":"M Kurata","year":"2006","unstructured":"Kurata M, Okura T, Watanabe S, Fukuoka T, Higaki J . Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci (Lond) 2006; 111: 319\u2013324.","journal-title":"Clin Sci (Lond)"},{"key":"BFhr2016110_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1161\/01.ATV.0000255560.49503.4e","volume":"27","author":"J Golledge","year":"2007","unstructured":"Golledge J, Muller J, Shephard N, Clancy P, Smallwood L, Moran C, Dear AE, Palmer LJ, Norman PE . Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2007; 27: 655\u2013660.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr2016110_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/hr.2011.177","volume":"35","author":"M Kurata","year":"2012","unstructured":"Kurata M, Okura T, Kumon Y, Tagawa M, Watanabe H, Nakahara T, Tatsuhiko M, Higaki J, Nose M . Plasma thrombin-cleaved osteopontin elevation after carotid artery stenting in symptomatic ischemic stroke patients. Hypertens Res 2012; 35: 207\u2013212.","journal-title":"Hypertens Res"},{"key":"BFhr2016110_CR14","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1001\/jama.292.15.1845","volume":"292","author":"LG Spagnoli","year":"2004","unstructured":"Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, Piepgras DG, Pistolese R, Ippoliti A, Holmes DR Jr. . Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004; 292: 1845\u20131852.","journal-title":"JAMA"},{"key":"BFhr2016110_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III . Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35\u201341.","journal-title":"Stroke"},{"key":"BFhr2016110_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1161\/01.STR.31.5.1081","volume":"31","author":"LJ Lee","year":"2000","unstructured":"Lee LJ, Kidwell CS, Alger J, Starkman S, Saver JL . Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 2000; 31: 1081\u20131089.","journal-title":"Stroke"},{"key":"BFhr2016110_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/01.STR.28.2.307","volume":"28","author":"LB Goldstein","year":"1997","unstructured":"Goldstein LB, Samsa GP . Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke 1997; 28: 307\u2013310.","journal-title":"Stroke"},{"key":"BFhr2016110_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J . Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604\u2013607.","journal-title":"Stroke"},{"key":"BFhr2016110_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/bimj.200410135","volume":"47","author":"R Fluss","year":"2005","unstructured":"Fluss R, Faraggi D, Reiser B . Estimation of the Youden Index and its associated cutoff point. Biom J 2005; 47: 458\u2013472.","journal-title":"Biom J"},{"key":"BFhr2016110_CR20","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1161\/ATVBAHA.107.144824","volume":"27","author":"M Scatena","year":"2007","unstructured":"Scatena M, Liaw L, Giachelli CM . Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 2302\u20132309.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr2016110_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1172\/JCI17778","volume":"112","author":"N Yamamoto","year":"2003","unstructured":"Yamamoto N, Sakai F, Kon S, Morimoto J, Kimura C, Yamazaki H, Okazaki I, Seki N, Fujii T, Uede T . Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest 2003; 112: 181\u2013188.","journal-title":"J Clin Invest"},{"key":"BFhr2016110_CR22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/ajh\/hps043","volume":"26","author":"T Wolak","year":"2013","unstructured":"Wolak T, Sion-Vardi N, Novack V, Greenberg G, Szendro G, Tarnovscki T, Nov O, Shelef I, Paran E, Rudich A . N-terminal rather than full-length osteopontin or its C-terminal fragment is associated with carotid-plaque inflammation in hypertensive patients. Am J Hypertens 2013; 26: 326\u2013333.","journal-title":"Am J Hypertens"},{"key":"BFhr2016110_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1161\/01.STR.31.3.615","volume":"31","author":"PM Rothwell","year":"2000","unstructured":"Rothwell PM, Gibson R, Warlow CP . Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and the risk of ischemic stroke in patients with symptomatic carotid stenosis. On behalf of the European Carotid Surgery Trialists\u2019 Collaborative Group. Stroke 2000; 31: 615\u2013621.","journal-title":"Stroke"},{"key":"BFhr2016110_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1055\/s-0037-1615895","volume":"82","author":"GD Lowe","year":"1999","unstructured":"Lowe GD, Rumley A . Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events. Thromb Haemost 1999; 82: 667\u2013672.","journal-title":"Thromb Haemost"},{"key":"BFhr2016110_CR25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0735-1097(99)00604-X","volume":"35","author":"PA Tunick","year":"2000","unstructured":"Tunick PA, Kronzon I . Atheromas of the thoracic aorta: clinical and therapeutic update. J Am Coll Cardiol 2000; 35: 545\u2013554.","journal-title":"J Am Coll Cardiol"},{"issue":"10 Suppl","key":"BFhr2016110_CR26","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1161\/STROKEAHA.110.596288","volume":"41","author":"BA Wasserman","year":"2010","unstructured":"Wasserman BA . Advanced contrast-enhanced MRI for looking beyond the lumen to predict stroke: building a risk profile for carotid plaque. Stroke 2010; 41 (10 Suppl): S12\u2013S16.","journal-title":"Stroke"},{"key":"BFhr2016110_CR27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/ana.21768","volume":"66","author":"AI Qureshi","year":"2009","unstructured":"Qureshi AI, Feldmann E, Gomez CR, Johnston SC, Kasner SE, Quick DC, Rasmussen PA, Suri MF, Taylor RA, Zaidat OO . Intracranial atherosclerotic disease: an update. Ann Neurol 2009; 66: 730\u2013738.","journal-title":"Ann Neurol"},{"key":"BFhr2016110_CR28","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1227\/NEU.0000000000000694","volume":"76","author":"W Yoon","year":"2015","unstructured":"Yoon W, Kim SK, Park MS, Kim BC, Kang HK . Endovascular treatment and the outcomes of atherosclerotic intracranial stenosis in patients with hyperacute stroke. Neurosurgery 2015; 76: 680\u2013686; discussion 686.","journal-title":"Neurosurgery"},{"key":"BFhr2016110_CR29","doi-asserted-by":"publisher","first-page":"e16185","DOI":"10.1371\/journal.pone.0016185","volume":"6","author":"J Hansson","year":"2011","unstructured":"Hansson J, Vasan RS, Arnlov J, Ingelsson E, Lind L, Larsson A, Michaelsson K, Sundstrom J . Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study. PLoS ONE 2011; 6: e16185.","journal-title":"PLoS ONE"},{"key":"BFhr2016110_CR30","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00004647-199605000-00002","volume":"16","author":"GA Rosenberg","year":"1996","unstructured":"Rosenberg GA, Navratil M, Barone F, Feuerstein G . Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 1996; 16: 360\u2013366.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFhr2016110_CR31","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1161\/01.STR.32.8.1759","volume":"32","author":"J Montaner","year":"2001","unstructured":"Montaner J, Alvarez-Sabin J, Molina C, Angles A, Abilleira S, Arenillas J, Gonzalez M, Monasterio J . Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 2001; 32: 1759\u20131766.","journal-title":"Stroke"},{"key":"BFhr2016110_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000199468","volume":"27","author":"P Dassan","year":"2009","unstructured":"Dassan P, Keir G, Brown MM . Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis 2009; 27: 295\u2013302.","journal-title":"Cerebrovasc Dis"},{"key":"BFhr2016110_CR33","doi-asserted-by":"publisher","first-page":"e86465","DOI":"10.1371\/journal.pone.0086465","volume":"9","author":"WJ Zi","year":"2014","unstructured":"Zi WJ, Shuai J . Plasma D-dimer levels are associated with stroke subtypes and infarction volume in patients with acute ischemic stroke. PLoS ONE 2014; 9: e86465.","journal-title":"PLoS ONE"},{"key":"BFhr2016110_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ab.2013.05.021","volume":"440","author":"S Funano","year":"2013","unstructured":"Funano S, Henares TG, Kurata M, Sueyoshi K, Endo T, Hisamoto H . Capillary-based enzyme-linked immunosorbent assay for highly sensitive detection of thrombin-cleaved osteopontin in plasma. Anal Biochem 2013; 440: 137\u2013141.","journal-title":"Anal Biochem"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/hr2016110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/hr2016110","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/hr2016110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T02:05:41Z","timestamp":1641002741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2016110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,25]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFhr2016110"],"URL":"https:\/\/doi.org\/10.1038\/hr.2016.110","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,25]]},"assertion":[{"value":"22 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}